Applied Sport Science Research Group and Experimental Nutrition Laboratory, Federal University of Alagoas (PPGNUT/PPGCS), Avenue Lourival Melo Mota, s/n, University City, Maceio 57072-900, Brazil.
The Human Performance Research Group, Technological Federal University of Parana, Pedro Gusso Street 2601, Neoville, Parana 81310900, Brazil.
Can J Physiol Pharmacol. 2020 Jan;98(1):23-28. doi: 10.1139/cjpp-2019-0459. Epub 2019 Oct 2.
The effect of chronic metformin intake on aerobic and anaerobic capacity was examined in healthy rats. Twenty rats completed 10 days of metformin (MET) ingestion (250 mg). After this period, the animals performed four high-intensity bouts until exhaustion at 9%, 11%, 13%, and 15% of body mass (BM) in swimming, separated by 24 h, with prior metformin (250 mg) or placebo (PL). The critical load (CL) and anaerobic work capacity (AWC - ') were calculated and considered aerobic and anaerobic capacity, respectively. There was no difference in CL between the MET and PL groups ( > 0.05). The AWC - ' was higher in the MET group than in the PL group ( = 0.004). Time until exhaustion (seconds) at all bouts were higher ( < 0.004) in the MET group (9% of BM = 434.5 ± 267.3, 11% of BM = 269.6 ± 214.2, 13% of BM = 174.0 ± 40.9, 15% of BM = 146.6 ± 15.9) compared to the PL group (9% of BM = 96.4 ± 22.3, 11% of BM = 65.5 ± 13.4, 13% of BM = 51.1 ± 5.5, 15% of BM = 40.8 ± 7.5). Glucose concentration was higher at 90 and 120 min than at 0 and 30 min for the MET group (intragroup) during the oral glucose test tolerance; there was no difference between the MET and PL groups for area under curve. MET ingestion enhances AWC - ' and times to exhaustion but not aerobic capacity.
研究人员研究了慢性二甲双胍摄入对健康大鼠有氧和无氧能力的影响。20 只大鼠完成了 10 天的二甲双胍(MET)摄入(250mg)。在此期间,动物在游泳中以 9%、11%、13%和 15%的体重(BM)进行了四次高强度至力竭的爆发,间隔 24 小时,之前给予二甲双胍(250mg)或安慰剂(PL)。计算临界负荷(CL)和无氧工作能力(AWC- '),分别表示有氧和无氧能力。CL 在 MET 和 PL 组之间没有差异(>0.05)。MET 组的 AWC- '高于 PL 组(=0.004)。MET 组在所有回合的力竭时间(秒)都更高(<0.004)(9%BM=434.5±267.3,11%BM=269.6±214.2,13%BM=174.0±40.9,15%BM=146.6±15.9)与 PL 组相比(9%BM=96.4±22.3,11%BM=65.5±13.4,13%BM=51.1±5.5,15%BM=40.8±7.5)。口服葡萄糖耐量试验期间,MET 组的葡萄糖浓度在 90 和 120 分钟时高于 0 和 30 分钟时(组内);MET 和 PL 组之间在曲线下面积方面没有差异。MET 摄入增强 AWC- '和力竭时间,但不增强有氧能力。